Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment

Background. The approved tenofovir disoproxil fumarate (TDF) dose of 300 mg every 48 hours for adults with moderate renal impairment is often confusing and inconvenient. Using a new TDF formulation, we compared the pharmacokinetics of the standard dose with a dose of 150 mg once daily in HIV-infecte...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Infect Dis
Asıl Yazarlar: Cressey, Tim R., Avihingsanon, Anchalee, Halue, Guttiga, Leenasirimakul, Prattana, Sukrakanchana, Pra-ornsuda, Tawon, Yardpiroon, Jaisieng, Nirattiya, Jourdain, Gonzague, Podany, Anthony T., Fletcher, Courtney V., Klinbuayaem, Virat, Bowonwatanuwong, Chureeratana
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2015
Konular:
HIV/AIDS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607735/
https://ncbi.nlm.nih.gov/pubmed/25921689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ346
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller